CANNASSURE THERAPEUTICS LTD Inactive Instrument
Cannassure Therapeutics Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CSURE
IL0001110134
Healthcare Facilities & Services
| Sales 2022 | 33.78 128.45 | Sales 2023 | 11 41.82 | Capitalization | 4M 15.21M |
|---|---|---|---|---|---|
| Net income 2022 | -5M -19.01M | Net income 2023 | -1M -3.8M | EV / Sales 2022 | 1,023,292 x |
| Net Debt 2022 | 29.96M 114M | Net Debt 2023 | 434K 1.65M | EV / Sales 2023 | 403,186 x |
| P/E ratio 2022 |
-0.84
x | P/E ratio 2023 |
-2.24
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 81.66% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Ada Bar Kama
CEO | Chief Executive Officer | 54 | 22-03-30 |
Nir Peles
CHM | Chairman | 50 | 18-12-03 |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 19-06-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shimon Bar-Kama
BRD | Director/Board Member | 71 | 18-12-03 |
Nir Peles
CHM | Chairman | 50 | 18-12-03 |
Varda Kalal
BRD | Director/Board Member | 56 | 22-02-13 |
Cannassure Therapeutics Ltd, formerly Direct Capital Investments Ltd, is an Israel-based real estate company. The Company has two main business activities; Yielding real estate and real estate investments in which the Company, directly and through its subsidiaries; locates, purchases, rents, upgrades and manages real estate. The Company and its subsidiaries have investments and property rights in Germany, Serbia, India, Kazakhstan, Latvia and Israel.
| 1st Jan change | Capi. | |
|---|---|---|
| +27.84% | 272M | |
| +28.81% | 269M | |
| +48.84% | 200M | |
| +38.04% | 134M | |
| -41.00% | 124M | |
| -28.57% | 121M | |
| +115.91% | 120M | |
| +150.00% | 75.33M | |
| -3.85% | 66.62M |
